Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|---|
![]() |
![]() |
![]() |
|||||||
GSM7798068 |
Control C4 Blood scTCRseq (biol rep 1)
|
SRA | 1 |
|
Shelli Farhadian | Apr 15, 2024 | |||
GSM7798070 |
Control C4 CSF scTCRseq
|
SRA | 1 |
|
Shelli Farhadian | Apr 15, 2024 | |||
GSM7798072 |
Control C4 Blood scTCRseq (biol rep 2)
|
SRA | 1 |
|
Shelli Farhadian | Apr 15, 2024 | |||
GSM7798074 |
Control C5 Blood scTCRseq (biol rep 1)
|
SRA | 1 |
|
Shelli Farhadian | Apr 15, 2024 | |||
GSM7798076 |
Control C5 CSF scTCRseq
|
SRA | 1 |
|
Shelli Farhadian | Apr 15, 2024 | |||
GSM7798078 |
Control C5 Blood scTCRseq (biol rep 2)
|
SRA | 1 |
|
Shelli Farhadian | Apr 15, 2024 | |||
GSM7798080 |
Control C6 Blood scTCRseq (biol rep 1)
|
SRA | 1 |
|
Shelli Farhadian | Apr 15, 2024 | |||
GSM7798082 |
Control C6 CSF scTCRseq
|
SRA | 1 |
|
Shelli Farhadian | Apr 15, 2024 | |||
GSM7798084 |
Control C6 Blood scTCRseq (biol rep 2)
|
SRA | 1 |
|
Shelli Farhadian | Apr 15, 2024 | |||
GSM7798086 |
PWH P1 Visit 1 Blood scTCRseq
|
SRA | 1 |
|
Shelli Farhadian | Apr 15, 2024 | |||
GSM7798088 |
PWH P1 Visit 1 CSF scTCRseq
|
SRA | 1 |
|
Shelli Farhadian | Apr 15, 2024 | |||
GSM7798090 |
PWH P1 Visit 2 Blood scTCRseq
|
SRA | 1 |
|
Shelli Farhadian | Apr 15, 2024 | |||
GSM7798092 |
PWH P1 Visit 2 CSF scTCRseq
|
SRA | 1 |
|
Shelli Farhadian | Apr 15, 2024 | |||
GSM7798094 |
PWH P1 Visit 3 Blood scTCRseq
|
SRA | 1 |
|
Shelli Farhadian | Apr 15, 2024 | |||
GSM7798096 |
PWH P1 Visit 3 CSF scTCRseq
|
SRA | 1 |
|
Shelli Farhadian | Apr 15, 2024 | |||
GSM7798098 |
PWH P1 Visit 4 Blood scTCRseq
|
SRA | 1 |
|
Shelli Farhadian | Apr 15, 2024 | |||
GSM7798100 |
PWH P1 Visit 4 CSF scTCRseq
|
SRA | 1 |
|
Shelli Farhadian | Apr 15, 2024 | |||
GSM7798102 |
PWH P2 Blood scTCRseq
|
SRA | 1 |
|
Shelli Farhadian | Apr 15, 2024 | |||
GSM7798104 |
PWH P2 CSF scTCRseq
|
SRA | 1 |
|
Shelli Farhadian | Apr 15, 2024 | |||
GSM7798107 |
PWH P3 Blood scTCRseq (biol rep 1)
|
SRA | 1 |
|
Shelli Farhadian | Apr 15, 2024 |